These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 34653701)
1. Pregabalin augmentation of antidepressants in major depression - results from a European multicenter study. Dold M; Bartova L; Fugger G; Mitschek MM; Fabbri C; Serretti A; Mendlewicz J; Souery D; Zohar J; Montgomery S; Kasper S J Affect Disord; 2022 Jan; 296():485-492. PubMed ID: 34653701 [TBL] [Abstract][Full Text] [Related]
2. Add-on benzodiazepine treatment in patients with major depressive disorder - results from a European cross-sectional multicenter study. Dold M; Bartova L; Fugger G; Mitschek MMM; Kautzky A; Frey R; Montgomery S; Zohar J; Mendlewicz J; Souery D; Fabbri C; Serretti A; Kasper S Eur Neuropsychopharmacol; 2020 Dec; 41():70-80. PubMed ID: 33046351 [TBL] [Abstract][Full Text] [Related]
3. Melancholic features in major depression - a European multicenter study. Dold M; Bartova L; Fugger G; Kautzky A; Mitschek MMM; Fabbri C; Montgomery S; Zohar J; Souery D; Mendlewicz J; Serretti A; Kasper S Prog Neuropsychopharmacol Biol Psychiatry; 2021 Aug; 110():110285. PubMed ID: 33609603 [TBL] [Abstract][Full Text] [Related]
4. Clinical factors associated with augmentation treatment with second-generation antipsychotics and lithium in major depression - Results from a European multicenter study. Dold M; Bartova L; Kautzky A; Serretti A; Porcelli S; Souery D; Mendlewicz J; Montgomery S; Zohar J; Kasper S Eur Neuropsychopharmacol; 2018 Dec; 28(12):1305-1313. PubMed ID: 30446357 [TBL] [Abstract][Full Text] [Related]
5. Comorbid thyroid disease in patients with major depressive disorder - results from the European Group for the Study of Resistant Depression (GSRD). Fugger G; Dold M; Bartova L; Kautzky A; Souery D; Mendlewicz J; Serretti A; Zohar J; Montgomery S; Frey R; Kasper S Eur Neuropsychopharmacol; 2018 Jun; 28(6):752-760. PubMed ID: 29705022 [TBL] [Abstract][Full Text] [Related]
6. Comorbid hypertension in patients with major depressive disorder - Results from a European multicenter study. Fugger G; Dold M; Bartova L; Kautzky A; Souery D; Mendlewicz J; Serretti A; Zohar J; Montgomery S; Frey R; Kasper S Eur Neuropsychopharmacol; 2019 Jun; 29(6):777-785. PubMed ID: 31006562 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological treatment strategies in unipolar depression in European tertiary psychiatric treatment centers - A pharmacoepidemiological cross-sectional multicenter study. Dold M; Kautzky A; Bartova L; Rabl U; Souery D; Mendlewicz J; Porcelli S; Serretti A; Zohar J; Montgomery S; Kasper S Eur Neuropsychopharmacol; 2016 Dec; 26(12):1960-1971. PubMed ID: 27816317 [TBL] [Abstract][Full Text] [Related]
8. Clinical correlates of augmentation/combination treatment strategies in major depressive disorder. Dold M; Bartova L; Mendlewicz J; Souery D; Serretti A; Porcelli S; Zohar J; Montgomery S; Kasper S Acta Psychiatr Scand; 2018 May; 137(5):401-412. PubMed ID: 29492960 [TBL] [Abstract][Full Text] [Related]
9. Psychotic Features in Patients With Major Depressive Disorder: A Report From the European Group for the Study of Resistant Depression. Dold M; Bartova L; Kautzky A; Porcelli S; Montgomery S; Zohar J; Mendlewicz J; Souery D; Serretti A; Kasper S J Clin Psychiatry; 2019 Jan; 80(1):. PubMed ID: 30677267 [TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and treatment outcomes of patients with major depressive disorder and comorbid anxiety disorders - results from a European multicenter study. Dold M; Bartova L; Souery D; Mendlewicz J; Serretti A; Porcelli S; Zohar J; Montgomery S; Kasper S J Psychiatr Res; 2017 Aug; 91():1-13. PubMed ID: 28284107 [TBL] [Abstract][Full Text] [Related]
11. Low comorbid obsessive-compulsive disorder in patients with major depressive disorder - Findings from a European multicenter study. Dold M; Bartova L; Souery D; Mendlewicz J; Porcelli S; Serretti A; Zohar J; Montgomery S; Kasper S J Affect Disord; 2018 Feb; 227():254-259. PubMed ID: 29107818 [TBL] [Abstract][Full Text] [Related]
12. Evidence on sociodemographic and clinical correlates of antidepressant combination or augmentation with second-generation antipsychotics in major depressive disorder. Fugger G; Bartova L; Dold M; Fabbri C; Fanelli G; Zanardi R; Kautzky A; Zohar J; Souery D; Mendlewicz J; Montgomery S; Rujescu D; Serretti A; Kasper S Prog Neuropsychopharmacol Biol Psychiatry; 2022 Mar; 114():110480. PubMed ID: 34826558 [TBL] [Abstract][Full Text] [Related]
13. The Choice of Either Quetiapine or Aripiprazole as Augmentation Treatment in a European Naturalistic Sample of Patients With Major Depressive Disorder. Bartova L; Fugger G; Dold M; Kautzky A; Swoboda MMM; Rujescu D; Zohar J; Souery D; Mendlewicz J; Montgomery S; Fabbri C; Serretti A; Kasper S Int J Neuropsychopharmacol; 2022 Feb; 25(2):118-127. PubMed ID: 34637516 [TBL] [Abstract][Full Text] [Related]
14. The impact of comorbid post-traumatic stress disorder in patients with major depressive disorder on clinical features, pharmacological treatment strategies, and treatment outcomes - Results from a cross-sectional European multicenter study. Dold M; Bartova L; Kautzky A; Souery D; Mendlewicz J; Serretti A; Porcelli S; Zohar J; Montgomery S; Kasper S Eur Neuropsychopharmacol; 2017 Jul; 27(7):625-632. PubMed ID: 28579072 [TBL] [Abstract][Full Text] [Related]
15. Major Depression and the Degree of Suicidality: Results of the European Group for the Study of Resistant Depression (GSRD). Dold M; Bartova L; Fugger G; Kautzky A; Souery D; Mendlewicz J; Papadimitriou GN; Dikeos D; Ferentinos P; Porcelli S; Serretti A; Zohar J; Montgomery S; Kasper S Int J Neuropsychopharmacol; 2018 Jun; 21(6):539-549. PubMed ID: 29860382 [TBL] [Abstract][Full Text] [Related]
16. The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countries. Fugger G; Bartova L; Fabbri C; Fanelli G; Dold M; Swoboda MMM; Kautzky A; Zohar J; Souery D; Mendlewicz J; Montgomery S; Rujescu D; Serretti A; Kasper S Eur Arch Psychiatry Clin Neurosci; 2022 Jun; 272(4):715-727. PubMed ID: 34989830 [TBL] [Abstract][Full Text] [Related]
17. Real-world characteristics of European patients receiving SNRIs as first-line treatment for major depressive disorder. Bartova L; Fugger G; Dold M; Kautzky A; Fanelli G; Zanardi R; Albani D; Weidenauer A; Rujescu D; Souery D; Mendlewicz J; Montgomery S; Zohar J; Fabbri C; Serretti A; Kasper S J Affect Disord; 2023 Jul; 332():105-114. PubMed ID: 36958488 [TBL] [Abstract][Full Text] [Related]
18. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study. Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422 [TBL] [Abstract][Full Text] [Related]
19. Major Depression and Comorbid Diabetes - Findings from the European Group for the Study of Resistant Depression. Fugger G; Dold M; Bartova L; Kautzky A; Souery D; Mendlewicz J; Serretti A; Zohar J; Montgomery S; Frey R; Kasper S Prog Neuropsychopharmacol Biol Psychiatry; 2019 Aug; 94():109638. PubMed ID: 31054944 [TBL] [Abstract][Full Text] [Related]
20. Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants. Berman RM; Fava M; Thase ME; Trivedi MH; Swanink R; McQuade RD; Carson WH; Adson D; Taylor L; Hazel J; Marcus RN CNS Spectr; 2009 Apr; 14(4):197-206. PubMed ID: 19407731 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]